Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

NovaBay Pharmaceuticals Inc (NYSE American:NBY)

4.45
Delayed Data
As of Nov 21
 -0.125 / -2.73%
Today’s Change
2.25
Today|||52-Week Range
5.00
+34.85%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close4.58
Today’s open4.55
Day’s range4.45 - 4.60
Volume3,050
Average volume (3 months)13,466
Market cap$70.3M
Dividend yield--
Data as of 8:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+79.47%
Earnings growth (this year)+59.05%
Earnings growth (next 5 years)--
Revenue growth (last year)+171.56%
P/E ratioNM
Price/Sales2.61
Price/Book9.84

Competitors

 Today’s
change
Today’s
% change
--Innovative Pharmaceu...+0.00+2.08%
AGLEAeglea Bio Therapeut...-0.19-4.23%
RNNRexahn Pharmaceutica...0.000.00%
PTNPalatin Technologies...+0.10+11.06%
Data as of 8:00pm ET, 11/21/2017

Financials

Last reporting dateNovember 14, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$11.9M
Annual profit (last year)-$13.2M
Net profit margin-110.54%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Mark M. Sieczkarek
Chief Financial Officer
Jack J. McGovern
Corporate headquarters
Emeryville, California

Forecasts